Levodopa-induced hyperhomocysteinaemia in Parkinson's disease

Acta Neurol Scand. 2003 Jul;108(1):66-7. doi: 10.1034/j.1600-0404.2003.00135.x.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antiparkinson Agents / adverse effects*
  • Antiparkinson Agents / therapeutic use*
  • Homocysteine / blood
  • Homocysteine / drug effects
  • Humans
  • Hyperhomocysteinemia / blood
  • Hyperhomocysteinemia / chemically induced*
  • Hyperhomocysteinemia / genetics
  • Levodopa / adverse effects*
  • Levodopa / therapeutic use*
  • Parkinson Disease / blood
  • Parkinson Disease / drug therapy*
  • Parkinson Disease / genetics

Substances

  • Antiparkinson Agents
  • Homocysteine
  • Levodopa